Free Trial

Establishment Labs (ESTA) Stock Price, News & Analysis

Establishment Labs logo
$40.11 -0.70 (-1.72%)
Closing price 04:00 PM Eastern
Extended Trading
$40.12 +0.02 (+0.04%)
As of 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Establishment Labs Stock (NASDAQ:ESTA)

Key Stats

Today's Range
$39.11
$41.13
50-Day Range
$28.51
$46.20
52-Week Range
$28.16
$60.12
Volume
329,623 shs
Average Volume
425,080 shs
Market Capitalization
$1.16 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$57.40
Consensus Rating
Moderate Buy

Company Overview

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

Remove Ads

Establishment Labs Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
47th Percentile Overall Score

ESTA MarketRank™: 

Establishment Labs scored higher than 47% of companies evaluated by MarketBeat, and ranked 604th out of 930 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Establishment Labs has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Establishment Labs has only been the subject of 1 research reports in the past 90 days.

  • Read more about Establishment Labs' stock forecast and price target.
  • Earnings Growth

    Earnings for Establishment Labs are expected to grow in the coming year, from ($2.41) to ($1.83) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Establishment Labs is -15.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Establishment Labs is -15.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Establishment Labs has a P/B Ratio of 56.49. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Establishment Labs' valuation and earnings.
  • Percentage of Shares Shorted

    22.95% of the float of Establishment Labs has been sold short.
  • Short Interest Ratio / Days to Cover

    Establishment Labs has a short interest ratio ("days to cover") of 9.3.
  • Change versus previous month

  • Dividend Yield

    Establishment Labs does not currently pay a dividend.

  • Dividend Growth

    Establishment Labs does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    22.95% of the float of Establishment Labs has been sold short.
  • Short Interest Ratio / Days to Cover

    Establishment Labs has a short interest ratio ("days to cover") of 9.3.
  • Change versus previous month

  • News Sentiment

    Establishment Labs has a news sentiment score of 1.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.78 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Establishment Labs this week, compared to 4 articles on an average week.
  • Search Interest

    1 people have searched for ESTA on MarketBeat in the last 30 days.
  • MarketBeat Follows

    Only 1 people have added Establishment Labs to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Establishment Labs insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    11.44% of the stock of Establishment Labs is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    72.91% of the stock of Establishment Labs is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Establishment Labs' insider trading history.
Receive ESTA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Establishment Labs and its competitors with MarketBeat's FREE daily newsletter.

ESTA Stock News Headlines

Trump Allies Confirm Exec Order 14024 Triggers Dollar Collapse
Executive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth, your savings, and your retirement. When the dollar collapses, your savings could disappear overnight. With Trump threatening Russia with more sanctions, Russia is rushing to finalize their BRICS payment system aimed to destroy the U.S dollar.
Establishment Labs price target lowered to $60 from $75 at TD Cowen
BTIG Remains a Buy on Establishment Labs Holdings (ESTA)
Establishment Labs reports Q4 EPS ($1.19), consensus (66c)
See More Headlines

ESTA Stock Analysis - Frequently Asked Questions

Establishment Labs' stock was trading at $46.07 at the beginning of 2025. Since then, ESTA stock has decreased by 12.9% and is now trading at $40.11.
View the best growth stocks for 2025 here
.

Establishment Labs Holdings Inc. (NASDAQ:ESTA) announced its quarterly earnings data on Wednesday, February, 26th. The company reported ($0.98) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.64) by $0.34. The business earned $44.51 million during the quarter, compared to analysts' expectations of $44.45 million. Establishment Labs had a negative trailing twelve-month return on equity of 184.55% and a negative net margin of 46.13%.

Establishment Labs (ESTA) raised $50 million in an initial public offering (IPO) on Thursday, July 19th 2018. The company issued 3,100,000 shares at a price of $15.00-$17.00 per share. Jefferies and Cowen served as the underwriters for the IPO and BTIG was co-manager.

Shares of ESTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Establishment Labs investors own include PayPal (PYPL), NVIDIA (NVDA), Walt Disney (DIS), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD) and Intel (INTC).

Company Calendar

Last Earnings
2/26/2025
Today
4/01/2025
Next Earnings (Estimated)
5/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:ESTA
Fax
N/A
Employees
960
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$57.40
High Stock Price Target
$70.00
Low Stock Price Target
$50.00
Potential Upside/Downside
+43.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-78,500,000.00
Pretax Margin
-46.87%

Debt

Sales & Book Value

Annual Sales
$166.03 million
Price / Cash Flow
N/A
Book Value
$0.71 per share
Price / Book
56.45

Miscellaneous

Free Float
24,795,000
Market Cap
$1.16 billion
Optionable
Optionable
Beta
0.95
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (NASDAQ:ESTA) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners